换一批Starc II, a multicenter randomized placebo-controlled double-blind clinical trial of trapidil for 1-year clinical events and angiographic restenosis reduction after coronary angioplasty and stenting.
第一作者：
Aleardo,Maresta
第一单位：
Division of Cardiology, Ospedale "S. Maria delle Croci," Ravenna, Italy. ra.hocardio@ausl.ra.it
作者：
医学主题词
血管成形术, 气囊, 冠状动脉(Angioplasty, Balloon, Coronary);阿司匹林(Aspirin);血管假体植入(Blood Vessel Prosthesis Implantation);冠状血管造影术(Coronary Angiography);冠状动脉再狭窄(Coronary Restenosis);双盲法(Double-Blind Method);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);发病率(Incidence);男(雄)性(Male);中年人(Middle Aged);心肌缺血(Myocardial Ischemia);病人依从(Patient Compliance);血小板聚集抑制剂(Platelet Aggregation Inhibitors);安全(Safety);支架(Stents);噻氯匹定(Ticlopidine);曲匹地尔(Trapidil);治疗失败(Treatment Failure);治疗结果(Treatment Outcome)
DOI
10.1002/ccd.20290
PMID
15736248
发布时间
2016-11-24
- 浏览23
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
